Yidu Tech Inc. has announced its annual results for the fiscal year ended 31 March 2025. The company reported total revenue of RMB715.0 million, marking an 11.4% decrease from the previous year. This decline was attributed to changes in the external market environment and product portfolios. Despite the revenue drop, Yidu Tech managed to narrow its loss for the year to RMB135.2 million, a 38.9% reduction compared to the prior year. The company's Life Sciences Solutions segment experienced a significant revenue decrease of 23.7%, totaling RMB247.1 million. Meanwhile, the Big Data Platform and Solutions segment saw a 10.3% increase in revenue, amounting to RMB345.9 million. The Health Management Platform and Solutions segment reported a 28.0% decline in revenue, reaching RMB122.0 million. Yidu Tech highlighted improvements in internal operational efficiency and enhanced synergies among business segments as contributing factors to the reduced loss. The company also reported a decrease in net cash outflow from operating activities by 23.8% year-on-year. As of 31 March 2025, the company maintained sufficient cash reserves, with cash and cash equivalents, term deposits, and other bank balances totaling RMB3,309.1 million.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。